EUVIMEDObjevte EUVIMED
Crossref

p110CUX1 promotes acute myeloid leukemia progression via regulating pyridoxal phosphatase expression and activating PI3K/AKT/mTOR signaling pathway

Hongyan Zhang, Liang Zhong, Meng Wang, Peng Wan, Xuan Chu, Shuyu Chen, Ziwei Zhou, Xin Shao, Beizhong Liu

Molecular Carcinogenesis · 2024

DOI: 10.1002/mc.23793 ↗

At a glance

Journal article in Molecular Carcinogenesis, 2024. Written by Hongyan Zhang and 8 co-authors. Institution: Central Laboratory of Yongchuan Hospital, Chongqing Medical University, Chongqing, China. Major MEDLINE topics: Cell Proliferation, Homeodomain Proteins, Leukemia, Myeloid, Acute, Phosphatidylinositol 3-Kinases. Cited 5 times so far (Crossref); 45 references. Funded by: National Natural Science Foundation of China, Chongqing Science and Technology Commission.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

As an evolutionarily conserved transcription factor, Cut‐like homeobox 1 (CUX1) plays crucial roles in embryonic and nervous system development, cell differentiation, and DNA damage repair. One of its major isoforms, p110CUX1, exhibits stable DNA binding capabilities and contributes to the regulation of cell cycle progression, proliferation, migration, and invasion. While p110CUX1 has been implicated in the progression of various malignant tumors, its involvement in acute myeloid leukemia (AML) remains uncertain. This study aims to elucidate the role of p110CUX1 in AML. Our findings reveal heightened expression levels of both p110CUX1 and pyridoxal phosphatase (PDXP) in AML cell lines. Overexpression of p110CUX1 promotes AML cell proliferation while inhibiting apoptosis and differentiation, whereas knockdown of PDXP yields contrasting effects. Mechanistically, p110CUX1 appears to facilitate AML development by upregulating PDXP expression and activating the PI3K/AKT/mTOR signaling pathway. Animal experimental corroborate the pro‐AML effect of p110CUX1. These results provide experimental evidence supporting the involvement of the p110CUX1‐PDXP‐PI3K/AKT/mTOR axis in AML progression. Hence, targeting p110CUX1 may hold promise as a therapeutic strategy for AML.

Subjects

MeSH terms (MEDLINE)

Cell ProliferationHomeodomain ProteinsLeukemia, Myeloid, AcutePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal TransductionTOR Serine-Threonine KinasesAnimalsHumansMiceApoptosisCell Line, TumorDisease ProgressionRepressor ProteinsTranscription Factors

Author keywords

PDXPacute myeloid leukemiap110CUX1

Substances

Homeodomain ProteinsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRepressor ProteinsTOR Serine-Threonine KinasesMTOR protein, humanCUX1 protein, humanTranscription Factors

Authors and institutions

  • Central Laboratory of Yongchuan Hospital, Chongqing Medical University, Chongqing, China.
  • Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, Department of Laboratory Medicine, Chongqing Medical University, Chongqing, China.

Funding

  • National Natural Science Foundation of China
  • Chongqing Science and Technology Commission

Cite

APA

Zhang, H., Zhong, L., Wang, M., Wan, P., Chu, X., Chen, S., Zhou, Z., Shao, X., & Liu, B. (2024). p110CUX1 promotes acute myeloid leukemia progression via regulating pyridoxal phosphatase expression and activating PI3K/AKT/mTOR signaling pathway. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23793

Vancouver

Zhang H, Zhong L, Wang M, Wan P, Chu X, Chen S, et al. p110CUX1 promotes acute myeloid leukemia progression via regulating pyridoxal phosphatase expression and activating PI3K/AKT/mTOR signaling pathway. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23793

BibTeX
@article{Zhang2024,
  author = {Zhang, Hongyan and Zhong, Liang and Wang, Meng and Wan, Peng and Chu, Xuan and Chen, Shuyu and Zhou, Ziwei and Shao, Xin and Liu, Beizhong},
  title = {p110CUX1 promotes acute myeloid leukemia progression via regulating pyridoxal phosphatase expression and activating PI3K/AKT/mTOR signaling pathway},
  journal = {Molecular Carcinogenesis},
  year = {2024},
  doi = {10.1002/mc.23793}
}
Start for free →